Karyopharm Therapeut (KPTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -76,422 | -45,642 | -13,570 | -37,362 | -143,099 |
| Depreciation Amortization | 4,205 | 2,159 | 200 | -618 | -2,754 |
| Accounts receivable | -3,804 | -4,816 | -11,033 | -4,120 | 20,124 |
| Accounts payable and accrued liabilities | 1,984 | 2,660 | -326 | 1,905 | 350 |
| Other Working Capital | -302 | -9,710 | -20,189 | -10,715 | 31,421 |
| Other Operating Activity | -53,147 | -46,327 | -37,305 | 7,185 | 1,235 |
| Operating Cash Flow | $-127,486 | $-101,676 | $-82,223 | $-43,725 | $-92,723 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142 | -195 | -195 | -195 | N/A |
| Purchase Of Investment | -58,822 | -57,316 | -36,511 | -31,608 | -159,151 |
| Sale Of Investment | 154,437 | 138,187 | 109,908 | 53,743 | 167,091 |
| Investing Cash Flow | $95,473 | $80,676 | $73,202 | $21,940 | $7,940 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 83,300 | 83,300 | 83,300 | N/A | N/A |
| Common Stock Issued | 1,452 | 772 | 772 | N/A | 1,124 |
| Other Financing Activity | -43,106 | -43,106 | -43,106 | 0 | 0 |
| Financing Cash Flow | $41,646 | $40,966 | $40,966 | $N/A | $1,124 |
| Exchange Rate Effect | -11 | 9 | -27 | -16 | -34 |
| Beginning Cash Position | 53,192 | 53,192 | 53,192 | 53,192 | 136,885 |
| End Cash Position | 62,814 | 73,167 | 85,110 | 31,391 | 53,192 |
| Net Cash Flow | $9,622 | $19,975 | $31,918 | $-21,801 | $-83,693 |
| Free Cash Flow | |||||
| Operating Cash Flow | -127,486 | -101,676 | -82,223 | -43,725 | -92,723 |
| Capital Expenditure | -142 | -195 | -195 | -195 | N/A |
| Free Cash Flow | -127,628 | -101,871 | -82,418 | -43,920 | -92,723 |